Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D Pharmaceutical Import Profile — Zambia (DGFT 2022–2026)

Name: Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D Pharmaceutical Import Records from India — 2 Products, $1.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D — Pharmaceutical Importer Profile (2026) | 2 Products, $1.3M Trade | TransData Nexus

Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D

Pharmaceutical Importer · Zambia · Advanced Antibiotics Focus · $1.3M Total Trade · DGFT Verified

Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D is a pharmaceutical importer based in Zambia with a total trade value of $1.3M across 2 products in 2 therapeutic categories. Based on 25 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D sources from 1 verified Indian supplier, with Missionpharma Logistics India Private Limited accounting for 100.0% of imports.

Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D — Import Portfolio & Supplier Network

Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Missionpharma Logistics India Private Limited	$3.4M	203	100.0%

Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D sources from 1 verified Indian supplier across 142 distinct formulations. The sourcing is highly concentrated — Missionpharma Logistics India Private Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Triclofem medroxyprogesterone	$363.8K	11
Metronidazole 200MG/hydrocortisone	$200.0K	4
Phenoxymethylpenicillin	$150.0K	3
Doxycycline 100MG as	$100.0K	2
Doxycycline 100MG as	$100.0K	2
Metronidazole 250MG/salbutamol	$81.8K	5
Cotrimoxazole 240MG/5ML 100ML	$52.2K	2
Oral rehydration salts 20.5g who	$50.0K	1
Hyoscine butylbromide 10MG(coo in india)	$50.0K	1
Albendazole 400MG chewable (coo	$50.0K	1
Bisoprolol 5MG (coo in india)	$50.0K	1
Doxycycline 100MG as	$50.0K	1
Phenoxymethylpenicillin 250MG	$50.0K	1
Amoxicillin 250MG dispersible(coo	$50.0K	1
Levonorgestrel 0.03MG microlut	$50.0K	1

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Metronidazole	Advanced Antibiotics	$700.0K	14	0.3%	12
2	Hydrocortisone	Corticosteroids	$550.0K	11	0.8%	7

Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D imports 2 pharmaceutical products across 2 categories into Zambia totaling $1.3M.

Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D is a pharmaceutical importer and buyer based in Zambia, specializing in the procurement of finished pharmaceutical formulations. The company operates as a key player in Zambia's pharmaceutical distribution network, focusing on the importation of essential medicines to meet the country's healthcare needs. While specific details about its headquarters, parent company, and exact role in the distribution chain are not publicly available, the company's activities suggest a significant presence in the Zambian pharmaceutical sector.

2Distribution Network

The distribution network of Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D is not publicly detailed. However, given its substantial import volume of $1.3 million USD from India over 25 shipments, it is likely that the company has established a robust logistics framework. This would include warehousing facilities and transportation capabilities to ensure the efficient distribution of pharmaceutical products across Zambia. The company's geographic coverage likely spans the entire country, facilitating the supply of essential medicines to both urban and rural areas.

3Industry Role

Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D plays a pivotal role in Zambia's pharmaceutical supply chain as a primary importer of finished pharmaceutical formulations. By sourcing a diverse range of medicines from India, the company contributes significantly to the availability of essential drugs in the Zambian market. Its activities support the healthcare system by ensuring a steady supply of quality-assured medicines, thereby enhancing the country's capacity to address public health challenges.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

The company's sourcing strategy exhibits a high degree of concentration, with all 25 shipments originating from a single supplier, MISSIONPHARMA LOGISTICS INDIA PRIVATE LIMITED. This single-source dependency could pose risks related to supply chain disruptions, such as delays or quality issues. However, the consistent relationship over multiple shipments suggests a stable and reliable partnership. To mitigate potential risks, it would be prudent for Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D to consider diversifying its supplier base, thereby enhancing supply chain resilience and reducing dependency on a single source.

2Supply Chain Resilience

The resilience of Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D's supply chain is closely tied to its exclusive relationship with MISSIONPHARMA LOGISTICS INDIA PRIVATE LIMITED. While this partnership has demonstrated reliability, the lack of alternative suppliers may expose the company to risks such as supply interruptions or regulatory changes affecting the sole supplier. The company's importation of 142 unique formulations indicates a diverse product portfolio, which can help mitigate some risks associated with product-specific supply issues. Nonetheless, establishing relationships with additional suppliers could further strengthen the company's supply chain resilience.

Importing Pharmaceuticals into Zambia — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Zambia

1Regulatory Authority & Framework

The Zambia Medicines Regulatory Authority (ZAMRA) is the statutory body responsible for regulating and controlling the manufacture, importation, storage, distribution, supply, sale, and use of medicines and allied substances in Zambia. Established under the Medicines and Allied Substances Act No. 3 of 2013, ZAMRA's primary objective is to ensure that all medicines and allied substances available to the Zambian public consistently meet the set standards of quality, safety, and efficacy. The authority oversees various regulatory activities, including marketing authorization, facility inspections, advertising and promotion, and post-marketing surveillance. (zamra.co.zm)

2Import Licensing & GMP

Importers of medicinal products into Zambia are required to obtain an import permit from ZAMRA. The application process involves paying a pre-clearance fee for quality assurance purposes. While holding a pharmaceutical license is not mandatory for importers, they must apply for a permit and pay the prescribed fee. ZAMRA has the authority to inspect premises where medicines are stored to ensure compliance with regulatory requirements. In cases of non-compliance, the authority can reject or revoke permits, and may require the disposal of non-compliant products at the importer's expense. (swm-programme.info)

Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D's focus on importing advanced antibiotics and corticosteroids aligns with the therapeutic needs of the Zambian population. The substantial import value of metronidazole and hydrocortisone indicates a strategic emphasis on these critical areas. The market demand for these products is driven by the prevalence of infections and inflammatory conditions in Zambia, necessitating a reliable supply of effective treatments. By concentrating on these therapeutic categories, the company plays a crucial role in addressing significant public health challenges.

2Sourcing Profile

Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D's sourcing strategy is centered on importing generic drugs from India, focusing on finished pharmaceutical formulations. The company's preference for a single supplier, MISSIONPHARMA LOGISTICS INDIA PRIVATE LIMITED, suggests a streamlined procurement process and potentially favorable terms. This approach allows the company to maintain a consistent supply of quality-assured products, ensuring the availability of essential medicines in the Zambian market.

3Market Positioning

Seller's Guide — How to Become a Supplier to Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Zambian market by partnering with Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D. The company's substantial import volume and focus on essential medicines indicate a steady demand for quality pharmaceutical products. To capitalize on this opportunity, Indian exporters should offer competitive pricing, ensure compliance with ZAMRA's regulatory standards, and demonstrate the ability to meet the specific needs of the Zambian market. Diversifying the supplier base could also enhance supply chain resilience and reduce dependency on a single source.

2Requirements & Qualifications

Indian exporters seeking to supply Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D and the Zambian market must adhere to ZAMRA's regulatory requirements. This includes obtaining the necessary import permits, ensuring compliance with Good Manufacturing Practices (GMP), and meeting quality assurance standards. Products must undergo batch testing and stability assessments, and labeling must meet specific language and content requirements. Additionally, exporters should be prepared to provide documentation demonstrating compliance with ZAMRA's regulations to facilitate the importation process.

Frequently Asked Questions — Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D

What products does Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D import from India?

Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D imports 2 pharmaceutical products across 2 categories. Top imports: Metronidazole ($700.0K), Hydrocortisone ($550.0K).

Who supplies pharmaceuticals to Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D from India?

Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D sources from 1 verified Indian suppliers. The primary supplier is Missionpharma Logistics India Private Limited (100.0% of imports, $3.4M).

What is Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D's total pharmaceutical import value?

Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D's total pharmaceutical import value from India is $1.3M, based on 25 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D focus on?

Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D imports across 2 categories. The largest: Advanced Antibiotics (56.0%), Corticosteroids (44.0%).

Get Full Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D

Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D?

What Formulations Does Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D Import?

What Products Does Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D Import?

Top Products by Import Value

Xxssixxphaxxa AXX Vxxsinxxrodxxj 9xx354xxlynxx D Therapeutic Categories — 2 Specializations